#novo
Related Stories (10)
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com
September 30, 2026Novo CEO says pills could capture 50% of weight-loss market by 2030 - Reuters
Novo CEO says pills could capture 50% of weight-loss market by 2030 Reuters
September 22, 2026Novo CEO urges staff to embrace more customer-focused culture - Reuters
Novo CEO urges staff to embrace more customer-focused culture Reuters
September 15, 2026Novo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026Obesity battle heats up again as Novo claws way back into race with Lilly - Reuters
Obesity battle heats up again as Novo claws way back into race with Lilly Reuters
August 3, 2026Novo's top US exec wants more insurance coverage for weight-loss drugs - Reuters
Novo's top US exec wants more insurance coverage for weight-loss drugs Reuters
June 25, 2026UK approves Novo weight-loss pill to edge open European market - Reuters
UK approves Novo weight-loss pill to edge open European market Reuters
June 11, 2026US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs - Reuters
US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs Reuters
April 30, 2026Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters
Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports Reuters
March 7, 2026Related Pages (9)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
US FDA proposes curbs on mass compounding of Novo, Lilly's weight-loss drugs
Published on 04/30/2026 at 09:58 am EDT - Modified on 04/30/2026 at 05:59 pm EDT April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa